Methadone is a registered Schedule 8 medication that is approved for the purpose of treating opioid dependence and withdrawal. Each jurisdiction is responsible for a system for authorising medical practitioners to prescribe methadone for the purpose of treating addiction. Prescribers must obtain authority for each patient. Check your jurisdictional policy for details of authorisation procedures (see Appendix 7 for contact details).

  • Patient identity must be verified at the time of assessment.

  • Patients must not begin methadone treatment until approval has been obtained from the jurisdictional authority.
Once authorisation has been obtained, commencement of methadone treatment should not be delayed. Successful commencement and continuation of treatment is enhanced by prompt program access.